- Home
- BCAL vs KMDA Comparison
BCAL vs KMDA Comparison
Compare BCAL & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAL
- KMDA
- Stock Information
- Founded
- BCAL 2001
- KMDA 1990
- Country
- BCAL United States
- KMDA Israel
- Employees
- BCAL N/A
- KMDA N/A
- Industry
- BCAL Major Banks
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- BCAL Finance
- KMDA Health Care
- Exchange
- BCAL Nasdaq
- KMDA Nasdaq
- Market Cap
- BCAL 471.0M
- KMDA 399.7M
- IPO Year
- BCAL N/A
- KMDA N/A
- Fundamental
- Price
- BCAL $14.53
- KMDA $7.20
- Analyst Decision
- BCAL Strong Buy
- KMDA Strong Buy
- Analyst Count
- BCAL 1
- KMDA 3
- Target Price
- BCAL $20.00
- KMDA $14.67
- AVG Volume (30 Days)
- BCAL 84.1K
- KMDA 71.8K
- Earning Date
- BCAL 07-28-2025
- KMDA 08-13-2025
- Dividend Yield
- BCAL N/A
- KMDA 2.77%
- EPS Growth
- BCAL N/A
- KMDA 31.21
- EPS
- BCAL 0.62
- KMDA 0.28
- Revenue
- BCAL $132,045,000.00
- KMDA $167,235,000.00
- Revenue This Year
- BCAL $74.16
- KMDA $14.51
- Revenue Next Year
- BCAL $4.92
- KMDA $9.31
- P/E Ratio
- BCAL $23.29
- KMDA $26.07
- Revenue Growth
- BCAL 42.63
- KMDA 11.83
- 52 Week Low
- BCAL $11.87
- KMDA $4.74
- 52 Week High
- BCAL $18.49
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- BCAL 48.10
- KMDA 65.83
- Support Level
- BCAL $14.07
- KMDA $6.78
- Resistance Level
- BCAL $15.04
- KMDA $7.09
- Average True Range (ATR)
- BCAL 0.40
- KMDA 0.16
- MACD
- BCAL -0.08
- KMDA 0.04
- Stochastic Oscillator
- BCAL 35.66
- KMDA 98.48
About BCAL Southern California Bancorp
California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through partnerships with its clients. The company has one operating segment: Commercial Banking.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.